Frazier Life Sciences Management, L.P. Pep Gen Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Pep Gen Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 702,694 shares of PEPG stock, worth $2.75 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
702,694
Previous 1,502,788
53.24%
Holding current value
$2.75 Million
Previous $24 Million
74.95%
% of portfolio
0.32%
Previous 1.41%
Shares
2 transactions
Others Institutions Holding PEPG
# of Institutions
60Shares Held
25.2MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$41.9 Million1.27% of portfolio
-
Janus Henderson Group PLC London, X02.34MShares$9.16 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.66MShares$6.51 Million0.56% of portfolio
-
Viking Global Investors LP1.48MShares$5.81 Million0.05% of portfolio
-
Perceptive Advisors LLC New York, NY1.41MShares$5.53 Million0.32% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $92.6M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...